Robert Davidson
Robert is Managing Editor of Applied Clinical Trials magazine. He received his B.S. degree in Magazine Journalism from the University of Maryland, College Park. Robert has significant experience in medical/scientific peer-review publishing, including a number of years with the IEEE Journals Department, where he managed 15 titles such as Transactions on Medical Imaging and Transactions on Nuclear Science. Earlier, he was an editorial researcher with National Magazine Award-winning IEEE Spectrum magazine. In 2003, he wrote a CME monograph covering COPD that was sponsored by GlaxoSmithKline. He has been with ACT for the past 3 years. In between his time with trade publications, Robert combined a personal interest and avocation as an editor with Field & Stream magazine, and he later gained public relations experience as a PR manager with Cendant Corporation.
Pfizer Reports Strong Phase III Results for Hympavzi in Hemophilia Patients with Inhibitors
June 26th 2025The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with hemophilia A or B with inhibitors, offering a promising new prophylactic option for a population with limited therapeutic choices.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.